Literature DB >> 8077614

Primary hyperparathyroidism and hypertension: persistently abnormal pressor sensitivity in normotensive patients after surgical cure.

J A Rodríguez-Portales1, C Fardella.   

Abstract

To examine the effects of primary hyperparathyroidism separately from those of hypertension per se on blood pressure regulation in patients with primary hyperparathyroidism, we studied the pressor response to infused angiotensin II (AII) and to norepinephrine (NE) in 7 normotensive patients with primary hyperparathyroidism before and after surgical cure, and compared it to that observed in 10 subjects with idiopathic hypertension and 10 normal controls. While the subjects were on an ad libitum diet, we measured urinary and plasma electrolytes, creatinine, and plasma renin activity. Except for calcium, these values were not significantly different among the three groups. The blood pressure was measured basally and in response to graded doses of AII or of NE until a 20-mmHg increase in the diastolic blood pressure was reached ("pressor dose"). The pressor doses of AII and of NE were lower in the normotensive patients with primary hyperparathyroidism than in normal controls [4.6 +/- 2.0 vs. 7.3 +/- 3.5 ng/kg/min (p < 0.05) and 164 +/- 114 vs. 302 +/- 176 ng/kg/min (p < 0.05) respectively] and not significantly different from those found in idiopathic hypertension (3.1 +/- 1.2 and 137 +/- 95 ng/kg/min). When the patients with primary hyperparathyroidism were studied again between 2-6 months after surgical cure, their pressor doses of AII and of NE remained unchanged from their preoperative values (5.4 +/- 2.9 and 137 +/- 80 mg/kg/min). We conclude that the hyperparathyroid condition can disrupt the normal responsiveness to pressor agents even if the blood pressure remains within normal limits, and that this abnormality may persist after surgical cure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077614     DOI: 10.1007/BF03348986

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  THE EFFECT OF ACUTE HYPERCALCEMIA UPON THE HEART OF THE INTACT DOG.

Authors:  G M MAXWELL; R B ELLIOTT; E S ROBERTSON
Journal:  Am J Cardiol       Date:  1964-06       Impact factor: 2.778

2.  Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects.

Authors:  A E DOYLE; J R FRASER; R J MARSHALL
Journal:  Clin Sci       Date:  1959-08       Impact factor: 6.124

3.  Hypertension in hyperparathyroidism.

Authors:  J HELLSTROM; G BIRKE; C A EDVALL
Journal:  Br J Urol       Date:  1958-03

4.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

5.  The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension.

Authors:  M GOLDENBERG; K L PINES
Journal:  Am J Med       Date:  1948-12       Impact factor: 4.965

6.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

7.  Primary hyperparathyroidism. Changing trends over fifty years.

Authors:  C Trigonis; B Hamberger; L O Farnebo; J Abarca; P O Granberg
Journal:  Acta Chir Scand       Date:  1983

8.  Primary hyperparathyroidism in Northern Sweden.

Authors:  A Kristoffersson; K Dahlgren; B Granstrand; J Järhult
Journal:  Surg Gynecol Obstet       Date:  1987-02

9.  Is parathyroidectomy of benefit in primary hyperparathyroidism?

Authors:  S Posen; P Clifton-Bligh; T S Reeve; C Wagstaffe; M Wilkinson
Journal:  Q J Med       Date:  1985-03

10.  Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests.

Authors:  F W Lafferty
Journal:  Arch Intern Med       Date:  1981-12
View more
  4 in total

1.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

2.  Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

Authors:  C Fardella; J A Rodriguez-Portales
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

3.  Hypertension Secondary to PHPT: Cause or Coincidence?

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Int J Endocrinol       Date:  2011-03-07       Impact factor: 3.257

4.  Parathyroid hormone may play a role in the pathophysiology of primary hypertension.

Authors:  Lasse Oinonen; Antti Tikkakoski; Jenni Koskela; Arttu Eräranta; Mika Kähönen; Onni Niemelä; Jukka Mustonen; Ilkka Pörsti
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.